DaVita Inc. Announces $750 Million Senior Notes Offering

Reuters
20 May
DaVita Inc. Announces $750 Million Senior Notes Offering

DaVita Inc. has announced a private offering of $750 million in senior notes due in 2033. The company plans to use the net proceeds from this offering to repay outstanding revolving credit facility borrowings, cover related costs, fees, and expenses, and, if any funds remain, for general corporate purposes such as repurchasing capital stock, working capital, and capital expenditures. The 2033 notes are being offered to qualified institutional buyers under Rule 144A of the Securities Act of 1933 and to certain non-U.S. persons in compliance with Regulation S under the Securities Act. The notes will not be registered under the Securities Act or any other jurisdiction's securities laws, and cannot be sold in the U.S. without registration or an applicable exemption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA90898) on May 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10